Endometrial Cancer Clinical Trials in Jacksonville, Florida
7 studies are recruiting for endometrial cancer in Jacksonville, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Phase 1 Study of the Safety and Tolerability of CTX-10726
This is a Phase 1, open-label, first-in-human study of CTX-10726 monotherapy in patients with metastatic or locally advanced malignancies. The study will be conducted in 2 Cohorts: Cohort 1 Dose Escalation and Cohort 2 Dose Expansion.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Mayo Clinic Florida, Jacksonville, Florida
- Locations
- 8 in total
- Run by
- Compass Therapeutics
-
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find the recommended dose of ART0380 that can be given safely to participants alone and in combination with gemcitabine or irinotecan * Learn more…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Mayo Clinic (Florida), Jacksonville, Florida
- Locations
- 88 in total
- Run by
- Artios Pharma Ltd
-
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
The overarching objective of this project is to develop a pan-gynecologic cancer detection test using gynecologic (unique endometrial, cervical, and ovarian cancer) cancer-specific methylated DNA markers and high-risk human papilloma virus (HR-HPV) detected in vaginal fluid and/or plasma. This prop…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic, Jacksonville, Florida
- Locations
- 25 in total
- Run by
- Mayo Clinic
-
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Phase I Study, a master protocol to investigate TCR-Engineered T cells recognizing KRAS mutations in adult subjects with Unresectable, Advanced, and/or Metastatic Solid Tumors.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Research Site, Jacksonville, Florida
- Locations
- 18 in total
- Run by
- AstraZeneca
-
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
A Study of Emi-Le in Participants with Solid Tumors
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Mayo Clinic - Jacksonville, Jacksonville, Florida
- Locations
- 26 in total
- Run by
- Day One Biopharmaceuticals, Inc.
-
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
This is a two-part, open-label, multicenter, dose escalation and dose expansion study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx), and anti- tumor activity of ETX-19477, a novel reversible small molecule inhibitor of PARG.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Mayo Clinic, Jacksonville, Florida
- Locations
- 14 in total
- Run by
- 858 Therapeutics, Inc.
-
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…
- Stage
- Not phased
- Ages
- Any age
- Site
- Massive Bio SYNERGY-AI site, Jacksonville, Florida
- Locations
- 68 in total
- Run by
- Massive Bio, Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.